C79 Price sensitive 19 Nov 2026, 8:24 AM

Pre AGM Trading Update Presentation

Chrysos Corporation Ltd

Chrysos Corporation Ltd Pre-AGM Trading Update

Key points

  • 27% growth in total revenue for the first four months of FY27
  • Record sample volumes of 4.91 million
  • Six new PhotonAssayTM units deployed and 15 new lease agreements signed
  • Reaffirmed FY27 revenue guidance of $108m to $118m
  • Well-funded with $19.5m cash and $120m in undrawn debt

Full summary

Chrysos Corporation Ltd has released a pre-AGM trading update for the period from July to October 2026, highlighting a robust performance. Total revenue grew by 27% compared to the prior corresponding period, reaching $36.7 million, with $22.6 million from MMAP and $13.7 million from AAC. The company has processed a record 4.91 million PhotonAssayTM samples, with the fleet sustaining above 90% availability. Chrysos has deployed six new units and signed 15 new lease agreements, bringing the total contracted units to 973. The company remains well-funded with a $19.5 million cash position and $120 million in undrawn debt. Chrysos has reaffirmed its FY27 guidance with a revenue range of $108 million to $118 million and an EBITDA range of $35 million to $42 million.

Guidance

FY27 Revenue range: $108m to $118m, EBITDA range: $35m to $42m

Outlook

Chrysos Corporation Ltd expects to continue its strong performance, driven by the ongoing global adoption of PhotonAssayTM and increasing demand from key miners and laboratories.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in